Alkyl Amines Reports Q1 Standalone Net Profit Of ₹95 Crore, EBITDA Margin Reaches 25.3%

Market snapshot: Alkyl Amines Chemicals has delivered a stellar performance for the first quarter of FY27, showcasing a robust surge in operational profitability and massive margin expansion. The company's standalone net profit rose nearly twofold, while operational efficiency reached a near cycle-high level.

Data Snapshot

• Standalone net profit for Q1 FY27 increased to ₹95 crore compared to ₹49.4 crore in Q1 FY26.
• EBITDA for Q1 FY27 jumped to ₹133 crore compared to ₹76.5 crore in the prior-year period.
• Operating EBITDA margin expanded significantly to 25.3% from 18.9% YoY.

What's Changed

• Standalone net profit grew by ≈109.39% QoQ to ₹95 crore from ₹45.37 crore in Q4 FY26, highlighting a quick and powerful sequential turnaround in market conditions and operating leverage.

Key Takeaways

• Massive Profit Increase: Standalone net profit rose by ≈92.3% YoY to ₹95 crore, indicating robust demand recovery and strategic pricing capability.
• Operational Efficiencies: EBITDA margin expansion of 640 basis points highlights strong cost control over key raw inputs such as ammonia and methanol.
• Accelerated Operational Cash: EBITDA grew by ≈73.86% YoY to ₹133 crore, strengthening the company's financial capability and capacity execution.

SAHI Perspective

Alkyl Amines' impressive Q1 FY27 results signal that the worst of the cyclical specialty chemical slowdown is behind. The company has successfully realized operating leverage, which aligns with management's guidance from the Q4 FY26 earnings call where they forecasted an improved margin outlook for FY27. This strong recovery confirms that the specialty chemical segment is moving out of destocking phases.

Market Implications

The significant margin expansion and bottom-line recovery are expected to drive highly positive investor sentiment. With the aliphatic amines duopoly (along with Balaji Amines) enjoying a high market share, this profit turnaround will likely trigger a valuation re-rating of the stock as raw material headwind concerns subside.

Trading Signals

Market Bias: Bullish

Stellar Q1 earnings characterized by a ≈92.3% YoY bottom-line growth and a 640 bps margin expansion to 25.3% provide a highly supportive backdrop for near-term momentum.

Overweight: Specialty Chemicals, Pharmaceuticals, Agrochemicals

Trigger Factors:

• Sustained EBITDA margin levels above 22%
• Export volume recovery in key API markets
• Raw material price stability in subsequent quarters

Time Horizon: Near-term (0-3 months)

Industry Context

The Indian aliphatic amines market operates as a virtual duopoly. Following a subdued FY26 marked by inventory destocking from pharmaceutical and agrochemical sectors, the first-quarter results of FY27 confirm a strong structural demand shift and raw material cost optimization for domestic manufacturers.

Key Risks to Watch

• Geopolitical developments impacting raw material supply chains and shipping costs.
• Pricing volatility in essential inputs like methanol and ammonia.
• Subdued demand recovery in key international export regions.

Recent Developments

Recent key developments include the company publishing physical share transfer notices as per SEBI regulations on July 29, 2026. Prior to this, Alkyl Amines held its 46th Annual General Meeting on July 3, 2026, where shareholders approved a final dividend of ₹10 per share (500% on face value of ₹2 each) for FY26.

Closing Insight

Alkyl Amines' remarkable Q1 FY27 outperformance confirms a strong fundamental reversal in specialty chemicals, placing the company in a prime position to leverage structural sector tailwinds in the coming quarters.

High Performance Trading with SAHI.